R&D The value of unstructured data for drug companies Advancements in medical AI now allow pharmaceutical companies to leverage unstructured clinical data at scale.
Digital “Data is our currency” – with Ginkgo Datapoints’ John Andros... Successful use of AI is becoming a key differentiator for pharma companies.
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
